Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
why wont the company put out news about all the patents? I believe that would be great news to let the street and investors now how well the company is doing. Additionally the company never defends them self's from the short players and the news they put out stating the company is not worth the current valuation!
I believe the stock won't move because there is so many shares out!!! or am I incorrect?
You needed to buy on the 16th to get the spin-off shares!!
You need to hold the stock (PFE) until the 11/17 Ex date in order to be entitled to shares record date is only for the share holders that hold stock, but ex date is for traders buying and selling with the due bill!!! Of the divided shares!!
how negative is this to the stock? i have been buying all the way down... should i give up with an average of $5.00?
they sold at an average of 4.37 correct? or are they still selling?
the mixed shelf registration could be positive, if the company is looking to sell stock if potential positive news could be coming out!!! could have the stock ready to sell..
Are you saying the stock will continue to go back down ?
I just want know how a stock could trade over 466 million when there’s only 30 million shares out? Are the institutions short the stock, and is that legal?
The NIH claims joint ownership of Moderna's coronavirus vaccine
Bob Herman
Bob Herman
Illustration of an American flag made up of syringes and quarters.
Illustration: Annelise Capossela/Axios
The National Institutes of Health may own intellectual property that undergirds a leading coronavirus vaccine being developed by Moderna, according to documents obtained by Axios and an analysis from Public Citizen.
Why it matters: Because the federal government has an actual stake in this vaccine, it could try to make the vaccine a free or low-cost public good with wide distribution, if the product turns out to be safe and effective.
The big picture: The NIH mostly funds outside research, but it also often invents basic scientific technologies that are later licensed out and incorporated into drugs that are sold at massive profits. The agency rarely claims ownership stakes or pursues patent rights, but that appears to be different with this coronavirus vaccine.
"We do have some particular stake in the intellectual property" behind Moderna's coronavirus vaccine, NIH Director Francis Collins said during an Economic Club interview in May.
Driving the news: New evidence shines light on the extent of NIH's involvement.
NIH and Moderna have researched coronaviruses, like MERS, for several years, and signed a contract this past December that stated "mRNA coronavirus vaccine candidates [are] developed and jointly owned" by the two parties. The contract was not specific to the novel coronavirus, and it was signed before the new virus had been sequenced.
Separately, four NIH scientists have filed for a provisional patent application entitled "2019-nCoV vaccine," according to disclosures in a pending scientific paper. Moderna scientists co-authored that paper, but none are listed as vaccine co-inventors.
That makes it clear "the government and the public have a stake" in the coronavirus vaccine, said Zain Rizvi, a health law and policy researcher at Public Citizen. "The vaccine would not exist without the intellectual contributions of federal scientists."
What they're saying: NIH said in a statement that its scientists created the "stabilized coronavirus spike proteins for the development of vaccines against coronaviruses, including SARS-CoV-2," and the government consequently has "sought patents to preserve the government's rights to these inventions."
Further, NIH "has adopted a non-exclusive licensing approach for these patent rights in order to allow multiple vaccine developers" to make a vaccine.
NIH added that "federal employees listed as inventors on these patent applications assigned their rights to the U.S. government. Accordingly, should the [United States Patent and Trademark Office] and other national patent authorities grant the patents, the U.S. government will hold ownership interest in the patents."
Moderna declined to comment beyond a statement, which said the company "has a broad owned and licensed IP estate" and is "not aware of any IP that would prevent us from commercializing our product candidates, including" the coronavirus vaccine.
Between the lines: Rizvi said co-owning the vaccine could allow NIH to more broadly license the underlying technology to other vaccine manufacturers "without the consent of Moderna," a company that is valued at $25 billion despite having no federally approved drugs on the market.
The bottom line: Many experts anticipate a coronavirus vaccine, once proven safe and effective, would be made as widely available as possible, and that developers aren't likely to seek big profits from it. Partial federal ownership could be a backstop if those assumptions don't bear out, but NIH isn't keen on stepping on industry's toes.
"Talking to the companies, I don't hear any of them say they think this [vaccine] is a money-maker," Collins said during his Economic Club interview. "I think they want to recoup their costs and maybe make a tiny percentage of increase of profit over that, like single digits percentage-wise, but that's it. Nobody sees this as a way to make billions of dollars."
Could anybody give me their opinion why NKLA is 66 dollars with no earnings and just renderings of trucks and WKHS is only 5 dollars?
Broker dealer working a not held trade all day printed the block at the average price.
Why is CURR over 3 dollars and GCAN that has almost the same technology is .16 cents?
FINRA requires market makers to report short selling on behalf of the clients to the street until the second part of the transaction the buy from the clients account. So it's not a real short.
could any body please tell me what is the difference between GCAN and CURR, why is that stock trading at 1.35?
I have tasted all flavors, and they are amazing. I don’t understand why the public does not know about the company. I have tasted other waters and this water is the best in the market by far!
No article is stating that MAXD is behind the lawsuit.
Yes, about 1 billion shares 2 weeks ago.
With almost 2 billion shares what would it take to move stock to .10?
why is it that know one is talking about the accumulation of a billion shares in two days? Someone already purchased control but has not followed the rules and filed with the Sec notifying the public. Very strange trading two weeks ago!
If Roy Meadows was the one that gave the money to the company for start up capital why is he a bad guy? The company took that cash and has developed a great product more than any other otc stock I have seen. The problem here is that the shorts will do anything to destroy the company I don't understand why the company is being attacked and no investigation into the people that are shorting the stock illegally.
We need to think that if the 70 Million shares from the conversions were not in the market the shares would be at 5 or 10 dollar's because of the interest and the short players selling stock that they should not be able to short legally.where is the SEC looking at these parties
What's wrong having notes to develop the product?